Lexaria's Patent Milestone and Its Impact on Drug Delivery Innovations

What is the significance of Lexaria reaching 50 patents worldwide?

Reaching 50 patents worldwide signifies Lexaria’s strong intellectual property protection and innovation in drug delivery, particularly with its DehydraTECH™ technology, enhancing its commercial potential and shareholder value.

What are the new patents Lexaria has received?

Lexaria has received a new patent in Australia for treating epilepsy and a new patent in Japan for the sublingual delivery of nicotine, expanding its patent portfolio in these areas.

How does the new epilepsy patent benefit Lexaria?

The new epilepsy patent in Australia broadens Lexaria’s intellectual property protection for epilepsy treatment outside the USA, complementing its existing patents and extending protection until 2044.

What is the expected market growth for epilepsy drugs?

The epilepsy drug market, valued at US$9.5 billion in 2023, is expected to reach over $15 billion by 2032, indicating significant growth potential for Lexaria’s technology in this sector.

How does the new nicotine delivery patent impact Lexaria’s market position?

The new patent in Japan for sublingual nicotine delivery strengthens Lexaria’s position in the growing global nicotine market, with existing patents in the USA and Canada, and protection until 2043.

What is the DehydraTECH™ technology?

DehydraTECH™ is Lexaria’s patented drug delivery platform that improves how active pharmaceutical ingredients enter the bloodstream through oral delivery, offering increased bio-absorption and effectiveness across the blood-brain barrier.

Who is involved in Lexaria’s nicotine market ventures?

Altria Ventures Inc., a 16.67% shareholder of Lexaria Nicotine LLC, holds a non-exclusive license to use DehydraTECH with nicotine products, indicating strategic partnerships in the nicotine market.

Where can I find more information about Lexaria and its technologies?

For more information about Lexaria Bioscience Corp. and its DehydraTECH™ technology, visit their official website at www.lexariabioscience.com.